 Enzo Biochem, Inc. NYSE:ENZ, a leading biotechnology and diagnostic company, today announced its wholly owned subsidiary, Enzo Clinical Labs, Inc., has expanded its screening services for COVID-19. Following the companys March 6, 2020 announcement regarding the initiation of accepting specimens for novel Coronavirus COVID-19 testing, Enzo is now directly collecting specimens at a drive-through facility by appointment in Enzos laboratory complex in Farmingdale, New York. This facility has been set up with support from local and state officials. 